Integra LifeSciences(FRA) IL3

Market Cap€1.11B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€14.40

+0.70%

+0.10Today

Integra LifeSciences Financials at a Glance

Market Cap

€1.11B

Revenue (TTM)

€1.41K

Net Income (TTM)

-€6.18

EPS (TTM)

-€0.08

P/E Ratio

-176.54

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Price

€14.40

Volume

Open

€14.40

Price

€14.40

Volume

Open

€14.40

Previous Close

€14.40

Daily Range

€14.40 - €14.40

52-Week Range

€7.60 - €17.30

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Price

€14.40

Volume

Open

€14.40

Previous Close

€14.40

Daily Range

€14.40 - €14.40

52-Week Range

€7.60 - €17.30

Estimated Earnings Date

N/A

IL3 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Integra LifeSciences

Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

4,427

CEO

Stuart M. Essig, PhD, MBA

Website

www.integralife.com

IL3 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-68.76%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-0.57%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€1.11B

Shares Outstanding

77.77M

Volume

Avg. Volume

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Integra LifeSciences Performance Analysis

Integra LifeSciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 1,482,116,143	13.6%
2023	2023-12-31	EUR 1,425,909,492	-3.8%
2024	2024-12-31	EUR 1,488,897,812	4.4%
2025	2025-12-31	EUR 1,448,942,892	-2.7%

Integra LifeSciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR 2.06	22.9%
2023	2023-12-31	EUR 0.78	-62.1%
2024	2024-12-31	EUR -0.08	N/A
2025	2025-12-31	EUR -5.97	7056.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€360.16

+1.0%

Gross Profit

€197.62

+1.0%

Gross Margin

54.87%

+1.0%

Market Cap

€1.11B

N/A

Market Cap/Employee

€0.29

N/A

Employees

4,427

N/A

Net Income

€3.85

-0.0%

EBITDA

€71.10

+1.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€1.98K

+4.1%

Total Debt

€1.79K

+1.0%

Accounts Receivable

€233.70

+1.0%

Inventory

€430.34

+1.1%

Long Term Debt

€1.74K

+1.5%

Short Term Debt

€50.31

+0.1%

Return on Assets

-19.80%

+0.0%

Return on Invested Capital

-1.20%

-0.4%

Free Cash Flow

€9.00

-1.3%

Operating Cash Flow

€19.66

+2.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About IL3

What is the current price of Integra LifeSciences?

Integra LifeSciences is trading at €14.40 per share.

What is the 52-week range for Integra LifeSciences?

Over the past 52 weeks, Integra LifeSciences has traded between €7.60 and €17.30.

How much debt does Integra LifeSciences have?

As of the most recent reporting period, Integra LifeSciences reported total debt of €1.79B.

How much cash does Integra LifeSciences have on hand?

Integra LifeSciences reported €187.54M in cash and cash equivalents in its most recent financial results.

What is Integra LifeSciences’s dividend yield?

Integra LifeSciences does not currently have a dividend yield.

Integra LifeSciences(FRA) IL3

Integra LifeSciences Financials at a Glance

IL3 News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Integra LifeSciences

IL3 Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Integra LifeSciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IL3

What is the current price of Integra LifeSciences?

What is the 52-week range for Integra LifeSciences?

How much debt does Integra LifeSciences have?

How much cash does Integra LifeSciences have on hand?

What is Integra LifeSciences’s dividend yield?

Premium Investing Services